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Multiple perspectives are generally required for a deep understanding of host-microbe interactions. Opportunistic pathogens, for
instance, may cause disease in humans by virtue of traits that evolved to deal with nonhuman environments. In the case of dedicated
human pathogens, it can be difficult to determine whether a particular disease symptom reflects a net benefit from the perspective of
either the host or the microbe or reflects a stalemate. Indeed, a major goal of Cell Host & Microbe is to serve as a forum that brings
together scientists with diverse perspectives—some focused more on the host, some focused more on the microbe—so that the
juxtaposition stimulates new ways of looking at, and ultimately answering, scientific questions of broad importance.
In this issue ofCell Host & Microbe,we are pleased to feature four Review articles, each discussing research directed at improving
global public health, that together exemplify the broad scope of the journal. In each case, this research is supported by the Bill & Me-
linda Gates Foundation, either through the Research and Development Network of the Pediatric Dengue Vaccine Initiative (Review by
Pierson et al.) or through theGrandChallenges inGlobal Health program (ReviewsbyYuandFinlay, Vaughan et al., andKaufmannand
Parida). Three Reviews describe research that could form the basis for creating new vaccines: Pierson et al. (page 229) describe how
antibodies either neutralize or enhance infection by flaviviruses, including dengue virus andWestNile encephalitis virus; Vaughan et al.
(page 209) describe how genetically attenuated malaria parasites defective in the liver stage of infection could be used as vaccines;
andKaufmann et al. (page 219) describe the search for host immunological biomarkers of protective immunity against tuberculosis. In
addition, Yu and Finlay (page 198) describe how the inflammasome protein complex in the host innate immune system can serve as
a tipping point in disease outcome and thus as a therapeutic drug target. These four Reviews, while highlighting research aimed at
improving human health, each reflect the power of considering both sides of the host-microbe equation.
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